VYNDAMAX

Indicated For

ATTR cardiomyopathy, transthyretin-mediated amyloidosis (ATTR-CM)

About This Medication

# Pfizer Patient Assistance Program Patient Guide: How to Get VYNDAMAX (tafamidis) at Low or No Cost VYNDAMAX (tafamidis) is a prescription medication used to treat transthyretin amyloid cardiomyopathy (ATTR-CM), a serious heart condition caused by abnormal protein buildup. The **Pfizer Patient Assistance Program (PAP)** offers VYNDAMAX at no cost to eligible uninsured or government-insured patients who meet income and other criteria, helping reduce financial barriers to this life-saving treatment.[1][2] ## About VYNDAMAX and Why Assistance Matters **VYNDAMAX** is an oral capsule taken daily to stabilize transthyretin proteins, slowing the progression of ATTR-CM. This condition affects the heart's ability to pump blood effectively, leading to symptoms like shortness of breath, fatigue, and swelling. Without treatment, it can worsen heart failure. VYNDAMAX has shown in clinical trials to reduce mortality and cardiovascular events, making it a critical therapy for eligible patients.[program details] The retail cost of VYNDAMAX can exceed $225,000 per year, far beyond what most people can afford out-of-pocket. That's where the Pfizer PAP steps in, providing free medication shipped directly to your home for those who qualify. This program is run jointly by Pfizer Inc. and the Pfizer Patient Assistance Foundation, ensuring broad access for those in need.[1][4] ## Who Qualifies for the Program? To qualify, you must: - Be 18 years or older and reside in the U.S. or a U.S. territory. - Have a valid prescription from a U.S.-licensed healthcare provider for outpatient use. - Be **uninsured** or have **government insurance** (e.g., Medicare, Medicaid) and be unable to afford your medication. - Meet income limits, typically up to **500% of the Federal Poverty Level (FPL)**, though exact household size thresholds are not publicly detailed and evaluated case-by-case. - Have an FDA-approved diagnosis (ATTR-CM for VYNDAMAX). **Commercially insured patients** (e.g., employer or marketplace plans) are **not eligible** for this free PAP; they should explore Pfizer's separate co-pay assistance program via Pfizer RxPathways.[2][3][9] ### Income Eligibility Breakdown Specific dollar thresholds vary by household size and are pegged to FPL (updated annually by the U.S. government). Pfizer PAP generally covers households at or below **500% FPL**. Use the table below as a guide (based on 2026 FPL estimates; confirm current levels at apply). | Household Size | 100% FPL | 400% FPL | 500% FPL (Typical PAP Limit) | |---------------|----------|----------|------------------------------| | 1 (Individual)| $15,060 | $60,240 | $75,300 | | 2 (Couple) | $20,440 | $81,760 | $102,200 | | 3 | $25,820 | $103,280| $129,100 | | 4 | $31,200 | $124,800| $156,000 | *Add ~$5,380 per additional person for 100% FPL. Income is pre-tax household total. Notes: Thresholds not explicitly detailed for VYNDAMAX; program evaluates proof of income. Uninsured/government-insured only.*[9][program details] Proof of income is required—no electronic verification option in some cases, so prepare documents early.[3] ## Insurance Requirements - **Uninsured**: Fully eligible if other criteria met. - **Government-insured** (Medicare Part D, Medicaid): Eligible if you can't afford costs. Medicare patients must attest to inability to pay, provide enrollment proof (e.g., Medicare ID), and may need to join the Medicare Prescription Payment Plan first.[7][9] - **Commercially insured**: Ineligible for free PAP. Try co-pay cards or Pfizer Oncology Together for savings. - No proof of U.S. citizenship needed, but a U.S. address is required.[2] Patients with certain meds may need to exhaust other aid (e.g., state programs) first.[2] ## Step-by-Step Application Process 1. **Discuss with your doctor**: Confirm VYNDAMAX prescription and get their help (they complete part of the form). 2. **Visit Pfizer RxPathways**: Go to www.PfizerRxPathways.com, use the Program Finder, enter "VYNDAMAX," and follow prompts.[1][2] 3. **Choose method** (multiple options): - **Online (Pfizer PAP Connect)**: Create account, upload docs, submit electronically—fastest for new/enrolled patients.[5][8] - **Phone**: Call (888) 222-8475 for guidance or manual forms.[program details] - **Download/Mail/Fax**: Get form from site, complete patient section, doctor signs, mail to P.O. Box 66585, St. Louis, MO 63166-6585 or fax 866-470-1748.[4] 4. **Gather documents**: - Proof of income (W-2, tax return pages 1-2, pay stubs, SSA-1099). - Proof of residency (U.S. address). - Proof of insurance status (cards or denial letters). - Prescription and diagnosis info.[program details][3][4] 5. **Sign consents**: Patient declaration of financial need; optional electronic income check.[3][9] 6. **Submit**: Doctor can fax with cover sheet. All pages required—no medical records.[4] **Reauthorization**: Yes, required periodically—use PAP Connect for refills.[program details][5] ## Timeline and Delivery Expect notification in **2-3 weeks** via letter with enrollment term (often 1 year) and next steps.[1][4] If approved, VYNDAMAX ships **free to your home**. Track status online via PAP Connect. Refills handled similarly—reauthorize as needed.[5][8] ## Alternatives if Denied or Ineligible - **Appeal**: Contact program if income/docs issue. - **Co-pay programs**: For commercial insurance via Pfizer RxPathways. - **State assistance**: Apply to Medicaid/State Exchange first if required.[2] - **Other PAPs**: PAN Foundation or NeedyMeds for ATTR-CM. - **Manufacturer co-pay card**: Up to $15,000/year savings for eligible. - **Patient Access Network (PAN)**: Grants for high copays. Shop generics/biosimilars: None available for VYNDAMAX.[program details] ## Important Disclaimer This guide is for informational purposes based on available program details as of 2026. Eligibility rules change; always verify at PfizerRxPathways.com or call (888) 222-8475. Pfizer may request more info or deny based on review. Not medical/financial advice—consult your doctor and advisor. Program excludes commercially insured; exhaust other options first. Word count: 1028.

Program information last verified: March 30, 2026